Disease-Vaccine-Landing-Page/side-panel/vaccine-complications

Individuals who experience an allergic reaction after a dose of Novavax COVID-19 vaccine should not receive another dose. Additionally, persons who are allergic to any component of the Novavax COVID-19...

Increased HIV infection riskCOVID-19 vaccines that use a recombinant adenovirus type-5 (Ad5) vector may increase the risk of HIV infection in males. In 2007, researchers testing an experimental HIV vaccine...

Individuals, especially women between the ages of 18 and 49, who receive the Janssen/Johnson & Johnson COVID-19 vaccine may be at risk for a serious and potentially fatal blood clot...

In early January 2022, the European Medicines Agency (EMA) expressed concerns over repeat COVID-19 vaccine booster shots and their impact on the immune system. European drug regulators reported that use...

According to a study published in The Lancet on May 12, 2021, adults 50 years and older who received a mixed dose combination of the Pfizer-BioNTech vaccine and the AstraZeneca...

The CDC cautions on the use of mRNA COVID-19 vaccines in persons who have a history of immediate allergic reaction to any injectable therapy or other vaccine, but state that...

Menstrual cycle changes have been reported following mRNA COVID-19 vaccines. These included reports such as heavy menstrual periods, menstruation following menopause, and breakthrough periods in women using birth control pills....

There is little safety data available on the use of COVID-19 vaccines or mRNA vaccines in pregnant women and only limited data available from animal development and reproductive toxicity studies....

Early COVID-19 vaccine clinical trials nearly exclusively enrolled healthy adults between the ages of 18 and 55 years. Few studies involve persons over the age of 65, or those with...

Young males, especially those under the age of 40 years, are at a significant risk of myocarditis and pericarditis following COVID-19 mRNA vaccination. In particular, males between 12 and 17...